The La Jolla Institute for Allergy & Immunology said today it has received a $12.6 million federal grant to establish the first publicly funded center in San Diego dedicated to research on RNA interference. Scientists are excited about the possibilities of RNAi research because it holds potential to silence specific malfunctioning genes involved in disease, which aren’t accessible by conventional small molecules or protein drugs. The new resource will be openly shared among researchers in San Diego and around the country, said Mitchell Kronenberg, the institute’s president and chief scientific officer, in a statement.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
